Full-Time

Psychiatrist

Adams Clinical

Adams Clinical

201-500 employees

Performs late-phase, double-blind psychiatric trials

Compensation Overview

$350k - $500k/yr

New York, NY, USA

In Person

On-site at New York research site.

Category
Medical, Clinical & Veterinary (1)

Get referred to Adams Clinical

See people who can refer or advise you

Requirements
  • Must be a psychiatrist and serve as Principal Investigator onsite at New York research sites
  • Individuals with both psychiatric and Alzheimer’s disease experience are especially encouraged to apply
  • Prior research experience is helpful but not required

Adams Clinical conducts late-phase psychiatric and neurologic clinical trials under FDA rules, using double-blind, randomized, placebo-controlled designs for investigational drugs that have advanced past initial testing. Nine full-time doctors serve as neutral third parties to oversee trials and ensure unbiased results; data integrity comes from careful participant selection and rigorous rater training. The company provides external testing required by law (Chapter 21 CFR Part 54) for pharmaceutical companies seeking evidence of efficacy and safety, generating revenue from sponsors. With high academic standards and small, focused trial numbers in depression research, Adams Clinical aims to deliver reliable data to support regulatory decisions on new psychiatric and neurologic drugs.

Company Size

201-500

Company Stage

N/A

Total Funding

N/A

Headquarters

Watertown, Massachusetts

Founded

2011

Get referred to Adams Clinical

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • InTandem Capital invested on May 21, 2024, funding growth and recruitment capacity.
  • Adams Clinical announced 2024 expansion into Dallas, Bronx, Harlem, and Watertown.
  • The 2026 website shows active studies across six locations, signaling operating momentum.

What critics are saying

  • Pharma site work depends on sponsor demand; any trial gap immediately hits utilization.
  • Inpatient expansion into 2025 raises execution risk across Watertown, Bronx, and Dallas.
  • A failed integration of InSite Clinical Research would weaken Adams Clinical's Texas foothold.

What makes Adams Clinical unique

  • Adams Clinical spans six metro sites across Boston, Bronx, Harlem, Philadelphia, Dallas, Watertown.
  • In 2024, it expanded into inpatient schizophrenia through InSite Clinical Research.
  • Its model emphasizes CNS trial speed, data integrity, and diverse patient recruitment.

Help us improve and share your feedback! Did you find this helpful?

Benefits

401(k) Company Match

Health Insurance

Dental Insurance

Vision Insurance

Health Savings Account/Flexible Spending Account

Paid Vacation

Parental Leave

Professional Development Budget

Life Insurance

Growth & Insights and Company News

Headcount

6 month growth

23%

1 year growth

23%

2 year growth

23%
BioSpace
Dec 11th, 2024
Adams Clinical Announces Expansion into Inpatient Psychiatry and Schizophrenia Clinical Trial Capabilities with Signing of Partnership with InSite Clinical Research

Adams Clinical announces expansion into inpatient Psychiatry and Schizophrenia clinical trial capabilities with signing of partnership with InSite Clinical Research.

BXTimes
Aug 22nd, 2024
Lease signed for new medical center at Hutchinson Metro Center

The real estate investment firm Simone Development Companies has inked a long-term lease agreement with medical research institute Adams Clinical, Inc. for the opening of a Davis Clinical medical research center at the Hutchinson Metro Center in the Bronx.

Business Wire
May 21st, 2024
InTandem Capital Partners Announces Investment in Adams Clinical

InTandem Capital Partners announces investment in Adams Clinical.